6-carboxyfluorescein has been researched along with Autoimmune Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deeg, CA; Gerhards, H; Kaspers, B; Reese, S; Wildner, G | 1 |
| Celli, CM; Chaimovich, H; Gharavi, AE | 1 |
2 other study(ies) available for 6-carboxyfluorescein and Autoimmune Diseases
| Article | Year |
|---|---|
The uveitogenic potential of retinal S-antigen in horses.
Topics: Animals; Arrestin; Autoantibodies; Autoantigens; Autoimmune Diseases; B-Lymphocytes; Enzyme-Linked Immunosorbent Assay; Epitopes; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Horse Diseases; Horses; Immunization; Immunoenzyme Techniques; Injections, Subcutaneous; Lymphocyte Activation; T-Lymphocytes; Uveitis | 2004 |
Opposite beta2-glycoprotein I requirement for the binding of infectious and autoimmune antiphospholipid antibodies to cardiolipin liposomes is associated with antibody avidity.
Topics: Antibodies, Anticardiolipin; Antibodies, Antiphospholipid; Antibody Affinity; Autoimmune Diseases; beta 2-Glycoprotein I; Cardiolipins; Epitopes; Fluoresceins; Fluorescent Dyes; Glycoproteins; Humans; Immunoglobulin G; Liposomes; Permeability; Syphilis | 1999 |